Skip to main content

Table 2 Demographic, drug use characteristics, and treatment history characteristics associated with expected frequency of use among PWID willing to use SIS

From: Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City

Characteristic

Expected frequency of SIS use

p valueb

Always or usually

(n = 106)

n (%)

Sometimes or occasionally

(n = 62)

n (%)

Gender

 Female

35 (62.5)

21 (37.5)

0.9100

 Male

71 (63.4)

41 (36.6)

Ethnicity

 White

78 (61.4)

49 (38.5)

0.4276

 Other

28 (68.3)

13 (31.7)

Housing

 Unstable

70 (68.6)

32 (31.4)

0.0447*

 Stable

36 (54.6)

30 (45.4)

Sex work

 Yes

17 (53.1)

15 (46.9)

0.1939

 No

89 (65.4)

47 (34.6)

Any public injectinga

 Yes

85 (67.5)

41 (32.5)

0.0460*

 No

20 (50.0)

20 (50.0)

Any injecting alonea

 Yes

94 (63.1)

55 (36.9)

0.9952

 No

12 (63.2)

7 (36.8)

Any help injectinga

 Yes

35 (64.8)

19 (35.2)

0.7506

 No

71 (62.3)

43 (37.7)

Syringe sharinga

 Yes

27 (69.2)

12 (30.8)

0.3480

 No

78 (60.9)

50 (39.1)

Daily opioidc injectinga

 Yes

74 (71.2)

30 (28.9)

0.0058*

 No

32 (50.0)

32 (50.0)

Daily crystal meth injectinga

 Yes

49 (76.6)

15 (23.4)

0.0045*

 No

57 (54.8)

47 (45.2)

Ever OD?

 Yes

30 (71.4)

12 (28.6)

0.1916

 No

74 (60.2)

49 (39.9)

Drug treatment history

 Yes

44 (62.0)

27 (38.0)

0.8066

 No

60 (63.8)

34 (36.2)

  1. *p < 0.05
  2. aIn the past 6 months
  3. bDetermined through chi-square tests or Fishers exact, where appropriate
  4. cOpioids include heroin, methadone (prescribed and non-prescribed), Hydros (Dilaudid and Hydromorph Contin), generic oxycodone, Oxy Neo, percocet, and fentanyl